Navigation Links
Raven Announces Completion of Enrollment in the Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for the Treatment of Adenocarcinomas
Date:2/13/2008

>

The trial was conducted at five institutions in the United States: The Sarah Cannon Cancer Center in Nashville, TN; The Fox Chase Cancer Center in Philadelphia, PA; Premiere Oncology in Santa Monica, CA; Georgetown University Medical Center in Washington, DC; and The University of Miami Medical Center in Miami, FL.

The RAV12 Phase 2 Program is expected to begin in the first quarter of 2008 when a first patient is enrolled in a study of gemcitabine plus RAV12 for the treatment of patients with metastatic pancreatic cancer. An additional Phase 2 study employing RAV12 is planned to begin in the second half of this year.

About RAV12

RAV12 is a novel, chimeric monoclonal antibody that is directed against a primate-specific glycotope (sugar structure) that is widely displayed on the surfaces of tumor cells, particularly those of gastrointestinal origin (gastroesophageal, pancreatic, and colorectal cancers). Preclinical studies have demonstrated that RAV12 may kill tumor cells in a number of ways: first, the antibody is directly cytotoxic to a human colon cancer cell line in vitro through induction of oncotic cell death, a form of cell death characterized by cell and organelle swelling and loss of membrane integrity; second, the antibody mediates antibody-dependent cellular cytotoxicity; third, the antibody mediates complement dependent cell killing; and finally, the antibody alters cellular signaling required for cell survival. RAV12 is highly efficacious in human colon, gastric, and pancreatic tumor xenograft models in vivo and has been found to be well tolerated in repeat dose primate toxicology studies.

About GI Cancers

Adenocarcinomas are malignant tumors of the epithelial cells that line glands or viscera. They typically spread by way of the circulatory or lymphatic systems and are poorly treated after metastatic spread. More than 90 percent of colon, stomach and pancreatic tumor specimens express the RAV12 defined antigen, RAAG
'/>"/>

SOURCE Raven biotechnologies, inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
2. Raven Announces Phase 1 Clinical Trial Results of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas
3. Raven Announces Continued Enrollment of Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Research and Markets has announced the addition of ... by Application & by Region- Global Trends & Forecasts to ... demand for membranes is estimated to increase at a CAGR ... Membrane technology was first commercialized in the 1960s ... kidney dialysis. In modern times, membranes find extensive application in ...
(Date:8/19/2014)... 19, 2014  Boehringer Ingelheim today announced that ... for review the New Drug Application (NDA) for ... delivered via the Respimat ® inhaler for ... of airflow obstruction in patients with chronic obstructive ... Tiotropium + olodaterol FDC will not be indicated ...
(Date:8/19/2014)... According to Kalorama Information, electronic medical records ... Data in healthcare a reality, and this a factor ... American Recovery and Reinvestment Act, the U.S. government dedicated ... penalties will start applying soon for use of paper ... study of the EMR industry, EMR 2014: The ...
Breaking Medicine Technology:Global Membranes (MF, RO, UF, Gas Separation, Dialysis, NF) Market - Forecasts to 2019 2Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 2Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 3Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 4Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 5Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 6Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 7Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 8Kalorama: EMR Paves the Way for Big Data 2Kalorama: EMR Paves the Way for Big Data 3
... Biosciences, a privately held company leading the development of ... McDonald, MBA, Senior Vice President and Chief Business Officer, ... Pennsylvania Convention Center in Philadelphia, Pennsylvania.  Ms. McDonald,s presentation ... November 10 in the Life Science Room #106AB and ...
... Nov. 3, 2010 Caliper Life ... leading provider of tools and services for drug ... collaboration with Sony DADC Austria AG for the ... next generation microfluidics products. The agreement combines Sony ...
Cached Medicine Technology:Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania 2Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania 3Caliper Life Sciences and Sony DADC Collaborate to Develop Plastic Microfluidic Solutions 2
(Date:8/20/2014)... Kowa Optimed returns after a short hiatus to ... SL-17 portable slit lamp. , The SL-17 has been ... by an illuminated thumb wheel for easy adjustments even ... AAA rechargeable and dry cell batteries, which is an ... specifically for the device. The new Sl-17 base design ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Riverside Health ... Dameron , who joined its Warsaw Medical Arts team ... specialized in Family Medicine, is accepting new patients. , ... of Medicine, completed his residency at the Mountain Area ... to Virginia. , “I really like the rural aspect ...
(Date:8/20/2014)... 20, 2014 This agreement will ... software defined networking, high availability cloud enablement, service, ... Resellers, while allowing OPEN-V to sell storageFOUNDRY’s expanding ... to work with OPEN-V on this distribution agreement ... manager distribution channels at storageFOUNDRY. "Nautilus is a ...
(Date:8/19/2014)... As moms and dads prepare their children to go back ... routine of dropping their little ones off at daycare with ... encourages them to use the opportunity to implement a new ... explains, “Kids have small tummies, short attention spans, and a ... handouts, use snack time as another daily opportunity to incorporate ...
(Date:8/19/2014)... (PRWEB) August 20, 2014 Midtown Dentistry in ... amalgam-free dental office. All patients with cavities, or with ... latest white fillings that can safely repair and restore teeth. ... the very latest materials, all of which are completely amalgam ... safe for use by the FDA for adults and children ...
Breaking Medicine News(10 mins):Health News:Kowa Optimed (Booth MS13043) to Debut New Portable Slit Lamp at 2014 Vision Expo West in Las Vegas, Nevada 2Health News:Riverside Warsaw Medical Arts’ Dr. William Dameron Accepting New Patients 2Health News:storageFOUNDRY and Open-V OzoneStack Announce Bilateral Distribution Agreement 2Health News:storageFOUNDRY and Open-V OzoneStack Announce Bilateral Distribution Agreement 3Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 2Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 3Health News:Midtown Dentistry Announces It Is Now an Amalgam-Free Office 2
... ... Save Lives in Healthcare Facilities and for Senior Care at Home. , ... (PRWEB) January 26, 2010 -- New inexpensive technologies ... effect of falls particularly in the population now approaching 60 and above. New personal use ...
... ... Cancer Care Delivery System , ... Washington, DC (Vocus) January 26, 2010 -- Community oncologists nationwide, under the ... urge President Obama and lawmakers to reverse drastic cuts in reimbursement for cancer care ...
... , Jan. 26 Milliman Care Guidelines LLC, ... that help health plans, hospitals and other clients optimize the ... software.   , The Care Guidelines promote quality ... on annually updated evidence, thus enabling informed and consistent clinical ...
... ... launched three new document scanners with rated speeds up to 60 images per minute ... models include a 2-Year manufacturer’s warranty, BulletScan Manager Software, and ABBYY FineReader® ... ...
... ... they are now offering Trek’s Ride+ electric assist bikes to their guests. By being one of ... opening up a new world of cycling vacations to a wider range of riders. Now anyone ... ...
... OAK BROOK, Ill. Preoperative computed tomography (CT) may ... with suspected acute appendicitis, according to a new study ... Radiology . "We found that rising utilization of ... in CT technology, coincided with a significant decrease in ...
Cached Medicine News:Health News:Medical Nurse Training, Inc and SaferFalls.com Announce New Products/Technologies to Save Lives in Healthcare Facilities and for Senior Home Care. 2Health News:Medical Nurse Training, Inc and SaferFalls.com Announce New Products/Technologies to Save Lives in Healthcare Facilities and for Senior Home Care. 3Health News:Community Oncologists Launch Petition to Stop Drastic Cancer Care Cuts 2Health News:Community Oncologists Launch Petition to Stop Drastic Cancer Care Cuts 3Health News:Milliman Care Guidelines Offers Online Interrater Reliability Tool and Training 2Health News:Milliman Care Guidelines Offers Online Interrater Reliability Tool and Training 3Health News:Milliman Care Guidelines Offers Online Interrater Reliability Tool and Training 4Health News:iVina Expands BulletScan Document Scanner Product Line Powered by ABBYY FineReader Technology 2Health News:iVina Expands BulletScan Document Scanner Product Line Powered by ABBYY FineReader Technology 3Health News:iVina Expands BulletScan Document Scanner Product Line Powered by ABBYY FineReader Technology 4Health News:Trek Travel Introduces Trek's Ride+ Electric Assist Bikes to Cycling Vacations 2Health News:Preoperative CT useful for younger women with suspected appendicitis 2
... The RCAI Hip Abduction Orthosis provides ... due to involved post-op hip revision, for ... dysphasia or to stabilize spastic, tight adductors ... ,The Hip Abduction Orthosis features flexion/extension ...
Modular hip abduction system designed to provide superior fit, adjustability and functionality for optimum patient stability, comfort and compliance...
... A Pavlik-type harness with greatly improved ... of congenital hip dysplasia. Color-coded straps, ... antislip foot pieces.,Color-coded anterior straps help ... be made while the child lies ...
... in walker design in years. A real step forward! ... surfaces of the foot rest on adaptive areas of ... strike. The footbed in the sole conforms to the ... stability. , ,No leg length discrepancy; Heel height ...
Medicine Products: